Sfoglia per Autore
Moving Toward Continuous Therapy in Multiple Myeloma
2019-01-01 Bonello, Francesca; Cetani, Giusy; Bertamini, Luca; Gay, Francesca; Larocca, Alessandra
Pursuing a curative approach in multiple myeloma: A review of new therapeutic strategies
2019-01-01 D'Agostino M.; Bertamini L.; Oliva S.; Boccadoro M.; Gay F.
Checkpoint inhibitors and myeloma: promises, deadlocks and new directions
2020-01-01 Bertamini, Luca; Gay, Francesca
When and How to Treat Relapsed Multiple Myeloma
2021-01-01 Nathwani, Nitya; Bertamini, Luca; Banerjee, Rahul; Gay, Francesca; Shah, Nina; Krishnan, Amrita
Development and Validation of a Simplified Score to Predict Early Relapse in Newly Diagnosed Multiple Myeloma in a Pooled Dataset of 2,190 Patients
2021-01-01 Zaccaria, Gian Maria; Bertamini, Luca; Petrucci, Maria Teresa; Offidani, Massimo; Corradini, Paolo; Capra, Andrea; Romano, Alessandra; Liberati, Anna Marina; Mannina, Donato; de Fabritiis, Paolo; Cascavilla, Nicola; Ruggeri, Marina; Mina, Roberto; Patriarca, Francesca; Benevolo, Giulia; Belotti, Angelo; Gaidano, Gianluca; Nagler, Arnon; Hájek, Roman; Spencer, Andrew; Sonneveld, Pieter; Musto, Pellegrino; Boccadoro, Mario; Gay, Francesca
Carfilzomib with cyclophosphamide and dexamethasone or lenalidomide and dexamethasone plus autologous transplantation or carfilzomib plus lenalidomide and dexamethasone, followed by maintenance with carfilzomib plus lenalidomide or lenalidomide alone for patients with newly diagnosed multiple myeloma (FORTE): a randomised, open-label, phase 2 trial
2021-01-01 Gay, Francesca; Musto, Pellegrino; Rota-Scalabrini, Delia; Bertamini, Luca; Belotti, Angelo; Galli, Monica; Offidani, Massimo; Zamagni, Elena; Ledda, Antonio; Grasso, Mariella; Ballanti, Stelvio; Spadano, Antonio; Cea, Michele; Patriarca, Francesca; D'Agostino, Mattia; Capra, Andrea; Giuliani, Nicola; de Fabritiis, Paolo; Aquino, Sara; Palmas, Angelo; Gamberi, Barbara; Zambello, Renato; Petrucci, Maria Teresa; Corradini, Paolo; Cavo, Michele; Boccadoro, Mario
MRD Assessment in Multiple Myeloma: Progress and Challenges
2021-01-01 Bertamini L.; D'Agostino M.; Gay F.
High Levels of Circulating Tumor Plasma Cells as a Key Hallmark of Aggressive Disease in Transplant-Eligible Patients With Newly Diagnosed Multiple Myeloma
2022-01-01 Bertamini, Luca; Oliva, Stefania; Rota-Scalabrini, Delia; Paris, Laura; Morè, Sonia; Corradini, Paolo; Ledda, Antonio; Gentile, Massimo; De Sabbata, Giovanni; Pietrantuono, Giuseppe; Pascarella, Anna; Tosi, Patrizia; Curci, Paola; Gilestro, Milena; Capra, Andrea; Galieni, Piero; Pisani, Francesco; Annibali, Ombretta; Monaco, Federico; Liberati, Anna Marina; Palmieri, Salvatore; Luppi, Mario; Zambello, Renato; Fazio, Francesca; Belotti, Angelo; Tacchetti, Paola; Musto, Pellegrino; Boccadoro, Mario; Gay, Francesca
Impact of minimal residual disease standardised assessment by FDG-PET/CT in transplant-eligible patients with newly diagnosed multiple myeloma enrolled in the imaging sub-study of the FORTE trial
2023-01-01 Zamagni, Elena; Oliva, Stefania; Gay, Francesca; Capra, Andrea; Rota-Scalabrini, Delia; D'Agostino, Mattia; Belotti, Angelo; Galli, Monica; Racca, Manuela; Zambello, Renato; Gamberi, Barbara; Albano, Domenico; Bertamini, Luca; Versari, Annibale; Grasso, Mariella; Sgherza, Nicola; Priola, Claudia; Fioritoni, Francesca; Patriarca, Francesca; De Cicco, Gabriella; Villanova, Tania; Pascarella, Anna; Zucchetta, Pietro; Tacchetti, Paola; Fanti, Stefano; Mancuso, Katia; Barbato, Simona; Boccadoro, Mario; Musto, Pellegrino; Cavo, Michele; Nanni, Cristina
Carfilzomib induction, consolidation, and maintenance with or without autologous stem-cell transplantation in patients with newly diagnosed multiple myeloma: pre-planned cytogenetic subgroup analysis of the randomised, phase 2 FORTE trial
2023-01-01 Mina, Roberto; Musto, Pellegrino; Rota-Scalabrini, Delia; Paris, Laura; Gamberi, Barbara; Palmas, Angelo; Aquino, Sara; de Fabritiis, Paolo; Giuliani, Nicola; De Rosa, Luca; Gozzetti, Alessandro; Cellini, Claudia; Bertamini, Luca; Capra, Andrea; Oddolo, Daniela; Vincelli, Iolanda Donatella; Ronconi, Sonia; Pavone, Vincenzo; Pescosta, Norbert; Cea, Michele; Fioritoni, Francesca; Ballanti, Stelvio; Grasso, Mariella; Zamagni, Elena; Belotti, Angelo; Boccadoro, Mario; Gay, Francesca
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Moving Toward Continuous Therapy in Multiple Myeloma | 2019 | Bonello, Francesca; Cetani, Giusy; Bertamini, Luca; Gay, Francesca; Larocca, Alessandra | |
| Pursuing a curative approach in multiple myeloma: A review of new therapeutic strategies | 2019 | D'Agostino M.; Bertamini L.; Oliva S.; Boccadoro M.; Gay F. | |
| Checkpoint inhibitors and myeloma: promises, deadlocks and new directions | 2020 | Bertamini, Luca; Gay, Francesca | |
| When and How to Treat Relapsed Multiple Myeloma | 2021 | Nathwani, Nitya; Bertamini, Luca; Banerjee, Rahul; Gay, Francesca; Shah, Nina; Krishnan, Amrita | |
| Development and Validation of a Simplified Score to Predict Early Relapse in Newly Diagnosed Multiple Myeloma in a Pooled Dataset of 2,190 Patients | 2021 | Zaccaria, Gian Maria; Bertamini, Luca; Petrucci, Maria Teresa; Offidani, Massimo; Corradini, Paolo; Capra, Andrea; Romano, Alessandra; Liberati, Anna Marina; Mannina, Donato; de Fabritiis, Paolo; Cascavilla, Nicola; Ruggeri, Marina; Mina, Roberto; Patriarca, Francesca; Benevolo, Giulia; Belotti, Angelo; Gaidano, Gianluca; Nagler, Arnon; Hájek, Roman; Spencer, Andrew; Sonneveld, Pieter; Musto, Pellegrino; Boccadoro, Mario; Gay, Francesca | |
| Carfilzomib with cyclophosphamide and dexamethasone or lenalidomide and dexamethasone plus autologous transplantation or carfilzomib plus lenalidomide and dexamethasone, followed by maintenance with carfilzomib plus lenalidomide or lenalidomide alone for patients with newly diagnosed multiple myeloma (FORTE): a randomised, open-label, phase 2 trial | 2021 | Gay, Francesca; Musto, Pellegrino; Rota-Scalabrini, Delia; Bertamini, Luca; Belotti, Angelo; Galli, Monica; Offidani, Massimo; Zamagni, Elena; Ledda, Antonio; Grasso, Mariella; Ballanti, Stelvio; Spadano, Antonio; Cea, Michele; Patriarca, Francesca; D'Agostino, Mattia; Capra, Andrea; Giuliani, Nicola; de Fabritiis, Paolo; Aquino, Sara; Palmas, Angelo; Gamberi, Barbara; Zambello, Renato; Petrucci, Maria Teresa; Corradini, Paolo; Cavo, Michele; Boccadoro, Mario | |
| MRD Assessment in Multiple Myeloma: Progress and Challenges | 2021 | Bertamini L.; D'Agostino M.; Gay F. | |
| High Levels of Circulating Tumor Plasma Cells as a Key Hallmark of Aggressive Disease in Transplant-Eligible Patients With Newly Diagnosed Multiple Myeloma | 2022 | Bertamini, Luca; Oliva, Stefania; Rota-Scalabrini, Delia; Paris, Laura; Morè, Sonia; Corradini, Paolo; Ledda, Antonio; Gentile, Massimo; De Sabbata, Giovanni; Pietrantuono, Giuseppe; Pascarella, Anna; Tosi, Patrizia; Curci, Paola; Gilestro, Milena; Capra, Andrea; Galieni, Piero; Pisani, Francesco; Annibali, Ombretta; Monaco, Federico; Liberati, Anna Marina; Palmieri, Salvatore; Luppi, Mario; Zambello, Renato; Fazio, Francesca; Belotti, Angelo; Tacchetti, Paola; Musto, Pellegrino; Boccadoro, Mario; Gay, Francesca | |
| Impact of minimal residual disease standardised assessment by FDG-PET/CT in transplant-eligible patients with newly diagnosed multiple myeloma enrolled in the imaging sub-study of the FORTE trial | 2023 | Zamagni, Elena; Oliva, Stefania; Gay, Francesca; Capra, Andrea; Rota-Scalabrini, Delia; D'Agostino, Mattia; Belotti, Angelo; Galli, Monica; Racca, Manuela; Zambello, Renato; Gamberi, Barbara; Albano, Domenico; Bertamini, Luca; Versari, Annibale; Grasso, Mariella; Sgherza, Nicola; Priola, Claudia; Fioritoni, Francesca; Patriarca, Francesca; De Cicco, Gabriella; Villanova, Tania; Pascarella, Anna; Zucchetta, Pietro; Tacchetti, Paola; Fanti, Stefano; Mancuso, Katia; Barbato, Simona; Boccadoro, Mario; Musto, Pellegrino; Cavo, Michele; Nanni, Cristina | |
| Carfilzomib induction, consolidation, and maintenance with or without autologous stem-cell transplantation in patients with newly diagnosed multiple myeloma: pre-planned cytogenetic subgroup analysis of the randomised, phase 2 FORTE trial | 2023 | Mina, Roberto; Musto, Pellegrino; Rota-Scalabrini, Delia; Paris, Laura; Gamberi, Barbara; Palmas, Angelo; Aquino, Sara; de Fabritiis, Paolo; Giuliani, Nicola; De Rosa, Luca; Gozzetti, Alessandro; Cellini, Claudia; Bertamini, Luca; Capra, Andrea; Oddolo, Daniela; Vincelli, Iolanda Donatella; Ronconi, Sonia; Pavone, Vincenzo; Pescosta, Norbert; Cea, Michele; Fioritoni, Francesca; Ballanti, Stelvio; Grasso, Mariella; Zamagni, Elena; Belotti, Angelo; Boccadoro, Mario; Gay, Francesca |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile